These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 32485920)
1. A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin-Proteasome System in Pulmonary Fibrosis. Roque W; Boni A; Martinez-Manzano J; Romero F Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485920 [TBL] [Abstract][Full Text] [Related]
2. Fine-tuning the ubiquitin-proteasome system to treat pulmonary fibrosis. Roque W; Summer R; Romero F Connect Tissue Res; 2019 Jan; 60(1):50-61. PubMed ID: 30343604 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. Craig VJ; Zhang L; Hagood JS; Owen CA Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236 [TBL] [Abstract][Full Text] [Related]
4. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Pardo A; Cabrera S; Maldonado M; Selman M Respir Res; 2016 Mar; 17():23. PubMed ID: 26944412 [TBL] [Abstract][Full Text] [Related]
5. Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis. Machahua C; Montes-Worboys A; Llatjos R; Escobar I; Dorca J; Molina-Molina M; Vicens-Zygmunt V Respir Res; 2016 Nov; 17(1):144. PubMed ID: 27816054 [TBL] [Abstract][Full Text] [Related]
6. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis. Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417 [TBL] [Abstract][Full Text] [Related]
7. Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis. Nkyimbeng T; Ruppert C; Shiomi T; Dahal B; Lang G; Seeger W; Okada Y; D'Armiento J; Günther A PLoS One; 2013; 8(9):e73279. PubMed ID: 24023851 [TBL] [Abstract][Full Text] [Related]
8. The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype. Mebratu YA; Soni S; Rosas L; Rojas M; Horowitz JC; Nho R Am J Physiol Cell Physiol; 2023 Sep; 325(3):C565-C579. PubMed ID: 37486065 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis. Mahalanobish S; Saha S; Dutta S; Sil PC Pharmacol Res; 2020 Feb; 152():104591. PubMed ID: 31837390 [TBL] [Abstract][Full Text] [Related]
10. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis. Pardo A; Selman M Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427 [TBL] [Abstract][Full Text] [Related]
11. Regulation of 26S Proteasome Activity in Pulmonary Fibrosis. Semren N; Welk V; Korfei M; Keller IE; Fernandez IE; Adler H; Günther A; Eickelberg O; Meiners S Am J Respir Crit Care Med; 2015 Nov; 192(9):1089-101. PubMed ID: 26207697 [TBL] [Abstract][Full Text] [Related]
12. Contributions of alveolar epithelial cell quality control to pulmonary fibrosis. Katzen J; Beers MF J Clin Invest; 2020 Oct; 130(10):5088-5099. PubMed ID: 32870817 [TBL] [Abstract][Full Text] [Related]
13. Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway. Inui N; Sakai S; Kitagawa M Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198949 [TBL] [Abstract][Full Text] [Related]
15. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation. Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970 [TBL] [Abstract][Full Text] [Related]
16. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis. Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339 [TBL] [Abstract][Full Text] [Related]
17. Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice. Bormann T; Maus R; Stolper J; Tort Tarrés M; Brandenberger C; Wedekind D; Jonigk D; Welte T; Gauldie J; Kolb M; Maus UA Respir Res; 2022 Jul; 23(1):180. PubMed ID: 35804363 [TBL] [Abstract][Full Text] [Related]
18. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4. Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983 [TBL] [Abstract][Full Text] [Related]
19. Osteopontin: an essential regulatory protein in idiopathic pulmonary fibrosis. Zhu X; Ji J; Han X J Mol Histol; 2024 Feb; 55(1):1-13. PubMed ID: 37878112 [TBL] [Abstract][Full Text] [Related]
20. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM. Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK Cells; 2021 Jun; 10(7):. PubMed ID: 34209854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]